drugset / Trial / NCT02009527
Arginase Inhibition in Ischemia-reperfusion Injury
RandomizedCrossoverSingle-blindBasic science
Summary
The present project is designed to test the hypothesis that arginase contributes to endothelial dysfunction induced by ischemia-reperfusion in patients with coronary artery disease.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-04
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-hydroxy-nor-arginine | Unknown | 0.1 mg | Other |